Pre-IPO Jiangxi Institute of Biological Products-Concerns Behind the Strong Growth and Profitability
​Jiangxi Institute of Biological Products leads in Human TAT with strong profitability, but future growth may slow. Technical barriers/global...
431 Views
CSI 100 Index Earning Revision (Jun): Industrial Bank, Satellite Chemical, Zhejiang Nhu
We analyzed CSI 100's consensus for Jun 2025 and highlighted changes of EPS in Industrial Bank (601166 CH), Satellite Chemical (002648 CH),...
351 Views
China Healthcare Weekly (Jan.12) - Haier Biomedical and RAAS Terminated Their Merger
​China's medical insurance fund will increase reimbursement for innovative drug. Commercial insurance need to increase percentage in hospital...
716 Views
China Healthcare Weekly (Dec.29) - Haier Biomedical Plans to Merge with and Absorb Shanghai RAAS
​Haier to merge with RAAS, enhancing dominance in blood products industry and improving financial performance.The deal is clearly more beneficial...
830 Views
(Desperate) Takeover Bid in the Making
Grifols' founding families and Brookfield ask the Board for the necessary information to evaluate an offer for 100% of Grifols SA (GRF SM). The...
374 Views